Decreased vasoconstrictor responses in remote cerebral arteries after focal brain ischemia and reperfusion in the rat, in vitro

European Journal of Pharmacology

Volumn 644, Issue 1-3, 2010, Pages 154-159

  Kovács, Anikó ^a   Móricz, Krisztina ^a   Albert, Mihály ^a   Benedek, Angéla ^a   Hársing, László G ^a   Szénási, Gábor ^a  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Ischemia; Middle cerebral artery; Remote effect; Reperfusion; Vascular dysfunction

Indexed keywords

REACTIVE OXYGEN METABOLITE; SEROTONIN; TIOPRONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BLOOD VESSEL REACTIVITY; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY; FUNCTIONAL ASSESSMENT; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; RENAL ARTERY; REPERFUSION; VASOCONSTRICTION;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL ARTERIES; FREE RADICAL SCAVENGERS; GLYCINE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SEROTONIN; SULFHYDRYL COMPOUNDS; TIME FACTORS; VASOCONSTRICTION;

EID: 77955776107     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.063     Document Type: Article

References (27)

1. Bolte C.S., Liao S., Gross G.J., Schultz J.J. Remote preconditioning-endocrine factors in organ protection against ischemic injury. Endocr. Metab. Immune Disord. Drug Targets 2007, 7:167-175.
2. Boselli C., Cozzi A., Rozza A., Favalli L., Govoni F., Govoni S. Acute cerebral focal ischaemia alters the adrenergic and NANC responses in the bisected rat vas deferens. Br. J. Pharmacol. 2002, 135:1723-1732.
3. Chen Y.S., Chien C.T., Ma M.C., Tseng Y.Z., Lin F.Y., Wang S.S., Chen C.F. Protection "outside the box" (skeletal remote preconditioning) in rat model is triggered by free radical pathway. J. Surg. Res. 2005, 126:92-101.
4. Cipolla M.J., Curry A.B. Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity. Stroke 2002, 33:2094-2099.
5. Cipolla M.J., McCall A.L., Lessov N., Porter J.M. Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats. Stroke 1997, 28:176-180.
6. Cipolla M.J., Lessov N., Clark W.M., Haley E.C. Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator. Stroke 2000, 31:940-945.
7. Cipolla M.J., Lessov N., Hammer E.S., Curry A.B. Threshold duration of ischemia for myogenic tone in middle cerebral arteries: effect on vascular smooth muscle actin. Stroke 2001, 32:1658-1664.
8. Haorah J., Ramirez S.H., Schall K., Smith D., Pandya R., Persidsky Y. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J. Neurochem. 2007, 101:566-576.
9. Hausenloy D.J., Yellon D.M. Preconditioning and postconditioning: united at reperfusion. Pharmacol. Ther. 2007, 116:173-191.
10. Henriksson M., Xu C.B., Edvinsson L. Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br. J. Pharmacol. 2004, 142:1155-1161.
11. Heyndrickx G.R. Early reperfusion phenomena. Semin. Cardiothorac. Vasc. Anesth. 2006, 10:236-241.
12. Hoyte L.C., Papadakis M., Barber P.A., Buchan A.M. Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res. 2006, 1121:231-237.
13. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
14. Marshman L.A. Preserved contractility without side bias in endovascular filament models for subarachnoid hemorrhage. J. Neurosci. Meth. 2002, 117:193-200.
15. Martinez-Revelles S., Jimenez-Altayo F., Caracuel L., Perez-Asensio F.J., Planas A.M., Vila E. Endothelial dysfunction in rat mesenteric resistance artery after transient middle cerebral artery occlusion. J. Pharmacol. Exp. Ther. 2008, 325:363-369.
16. Matucz E., Móricz K., Gigler G., Simó A., Barkóczy J., Lévay G., Hársing L.G., Szénási G. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia. Brain Res. 2004, 1019:210-216.
17. Petrault O., Bastide M., Cotelle N., Gele P., Gautier S., Laprais M., Vamecq J., Duriez P., Bordet R. The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction. Naunyn-Schmiedebergs Arch. Pharmacol. 2004, 370:395-403.
18. Petrault O., Ouk T., Gautier S., Laprais M., Gele P., Bastide M., Bordet R. Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion. Br. J. Pharmacol. 2005, 144:1051-1058.
19. Rubino A., Yellon D.M. Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart?. Trends Pharmacol. Sci. 2000, 21:225-230.
20. Seal J.B., Gewertz B.L. Vascular dysfunction in ischemia-reperfusion injury. Ann. Vasc. Surg. 2005, 19:572-584.
21. Stenman E., Edvinsson L. Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 2004, 35:970-974.
22. Stenman E., Malmsjo M., Uddman E., Gido G., Wieloch T., Edvinsson L. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 2002, 33:2311-2316.
23. Terao S., Yilmaz G., Stokes K.Y., Russell J., Ishikawa M., Kawase T., Granger D.N. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 2008, 39:2560-2570.
24. Trendelenburg G. Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response?. J. Cereb. Blood Flow Metab. 2008, 28:867-881.
25. Weinbrenner C., Schulze F., Sarvary L., Strasser R.H. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc. Res. 2004, 61:591-599.
26. Xie H., Ray P.E., Short B.L. NF-kappaB activation plays a role in superoxide-mediated cerebral endothelial dysfunction after hypoxia/reoxygenation. Stroke 2005, 36:1047-1052.
27. Yassin M.M., Harkin D.W., Barros D'Sa A.A., Halliday M.I., Rowlands B.J. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J. Surg. 2002, 26:115-121.